Presepsin as a potential marker for bacterial infection relapse in critical care patients. A preliminary study
Valeria Sargentini(Sapienza University of Rome), A. Bachetoni(Policlinico Umberto I), B Evangelista(Sapienza University of Rome), Giancarlo Ceccarelli(International Organization for Migration), Anna Nicoletti(Sapienza University of Rome), Antonio Angeloni(Policlinico Umberto I), Daniela Collepardo(Policlinico Umberto I), Sabrina Mariotti(Istituto Superiore di Sanità), Annalia D’Egidio(Sapienza University of Rome), Mario Venditti(Sapienza University of Rome), Gabriella d’Ettorre(Policlinico Umberto I), Mariadomenica D’Alessandro(Sapienza University of Rome), Andrea Morelli(Sapienza University of Rome)
Cited by 40
Related Papers
Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study
|The Lancet Infectious Diseases|2017|521
Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by<i>Klebsiella pneumoniae</i>Carbapenemase–producing<i>K. pneumoniae</i>
|Clinical Infectious Diseases|2018|351
Perspectives on alternatives to phthalate plasticized poly(vinyl chloride) in medical devices applications
|Progress in Polymer Science|2013|331
Levosimendan: Molecular mechanisms and clinical implications
|International Journal of Cardiology|2011|313
Post-Traumatic Stress Symptoms in Healthcare Workers Dealing with the COVID-19 Pandemic: A Systematic Review
|International Journal of Environmental Research and Public Health|2021|272